Editorial Note on Journal of Basic and Clinical Pharmacy Updates
Received: 22-Jul-2020 Accepted Date: Jul 29, 2020 ; Published: 03-Aug-2020
Citation: Nagaraja SH. Editorial Note on Journal of Basic and Clinical Pharmacy Updates. J Basic Clin Pharma 2020;11:4-4.
This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@jbclinpharm.org
Editorial
Journal of Basic & Clinical Pharmacy (p-ISSN: 0976-0105; e-ISSN: 0976-0113) is successfully publishing quality of research on all areas related to Pharmacy and Clinical Pharmacy. The current volume of the journal is 8 with issue 2. The journal expresses gratitude to all its elite panel of editorial board members for their continuous efforts, support and encouragement throughout the publication journey of the journal, right from its inception in the year 2019 we pride on providing a supportive and accessible service throughout the publishing process and congratulates them for making the journal achieve its goals and becoming successful as one of the leading and well-recognized broadcaster of scientific outcomes in the field of scientific work on Pharmacy.
The objective of JBCP is to publish high-quality original research papers, survey reports, case studies, narratives, review article, short communication, clinical data, thesis and relevant and insightful reviews. Every year we published with different volumes and different issues. Each issue of the journal covered with different types of topics in the field of Pharmacy, Clinical Pharmacy, Medication, Personalized Medical Research, Cancer genomics, Clinical research in genome, Biomarkers in geomic medicine and more. All published papers, are subject to the journal’s double-blind review process. The topics for the 2019 year were varied and exciting. The current volume of the journal is 11 with issue 3.
We believe your contribution will enhance the worth of the issue in 2020 in the field of Pharmacy Research include Medication, Clinical pharmacy, Personalized Medical Research, Cancer genomics, Clinical research in Patients, General medicine, scientific signification applications in plants and animals, cloning and more. The submitted papers will be 21 day rapid review process with international peer-review standards. Timeline of processing from Submission to Publication is 45 days. Manuscript will be published within 7days of acceptance.
The social media can play a key role in spreading the research work increased visibility, citation and ultimately the impact of published works. We promote published articles to the social media. This will benefit the researcher to increase reputation and attendant career progression. For example, the Facebook account, Twitter, LinkedIn and Instagram.
According to the Google Analytics, more than 3000 readers are visiting to our journal websites for submitting manuscripts, to browse the latest research published on genetics and to refer the published content for conceptualizing their research study, deriving research hypotheses, case reports and validating their contributions. Readers from the major countries including United States, Japan, United Kingdom, India, Egypt and Nigeria visit our journal domain to learn about the ongoing research activities in this field.
On behalf of the JBCP Editorial Board and the whole Editorial Office, I would like to express our gratefulness to the authors of articles published during the past years, and to acknowledge generous help which both the authors and editors obtained from the peer-reviewers.